DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas will moderate the panel “Driving Innovation from a VC Perspective” at the BioExec Institute Retreat in Florida on March 21, 2013.
News | 03. 21. 2013
Art Pappas will moderate a panel titled, “Driving Innovation from a VC Perspective” at the BioExec Institute Retreat in Florida on March 21, 2013.
